Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries (2020)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1016/j.ijcard.2020.01.070
- Subjects: ENVELHECIMENTO; INFARTO DO MIOCÁRDIO; FATORES DE RISCO; RESULTADO DE TRATAMENTO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: International journal of cardiology
- ISSN: 0167-5273
- Volume/Número/Paginação/Ano: v. 311, p. 7-14, 2020
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
BRIEGER, David et al. Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries. International journal of cardiology, v. 311, p. 7-14, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ijcard.2020.01.070. Acesso em: 29 dez. 2025. -
APA
Brieger, D., Pocockb, S. J., Blankenberg, S., Chen, J. Y., Cohen, M. G., Granger, C. B., et al. (2020). Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries. International journal of cardiology, 311, 7-14. doi:10.1016/j.ijcard.2020.01.070 -
NLM
Brieger D, Pocockb SJ, Blankenberg S, Chen JY, Cohen MG, Granger CB, Grieve R, Nicolau JC, Simon T, Westermann D. Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries [Internet]. International journal of cardiology. 2020 ; 311 7-14.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.ijcard.2020.01.070 -
Vancouver
Brieger D, Pocockb SJ, Blankenberg S, Chen JY, Cohen MG, Granger CB, Grieve R, Nicolau JC, Simon T, Westermann D. Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries [Internet]. International journal of cardiology. 2020 ; 311 7-14.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.ijcard.2020.01.070 - Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis TREAT trial
- Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial (vol 3, pg 391, 2018)
- Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF Trial
- Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age Insights From DAPA-HF
- Effect of alirocumab on mortality after acute coronary syndromes an analysis of the ODYSSEY OUTCOMES randomized clinical trial
- Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry
- Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54
- Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
- Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study
- Anticoagulação e antiagregação plaquetária nas síndromes isquêmicas miocárdicas instáveis [Carta]
Informações sobre o DOI: 10.1016/j.ijcard.2020.01.070 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
